Erythropoietin plus methylprednisolone versus methylprednisolone plus placebo in the treatment of acute spinal cord injury: A pilot study

Phase 2

Completed

• Conditions: Injuries and Accidents - Other injuries and accidents; Acute spinal cord injury

• Registration Number: ACTRN12609000602224
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-07-21
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Spinal cord injury presenting to emergency department within 6 hours after injury

Exclusion Criteria

only qauda equina or nerve root involvement

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eurologic examination for determination of American Spinal Injury Association (ASIA) scale[on admission,24 and 48 hours, one week, one and six months later]

Secondary Outcome Measures

Name	Time	Method
Rectal sphincter tone presence evaluated by rectal examination[on admission and one month later]